{"url":"https://lda.senate.gov/api/v1/filings/0a5d1a8a-eeaf-4fd8-bff8-d0a428aa2fee/","filing_uuid":"0a5d1a8a-eeaf-4fd8-bff8-d0a428aa2fee","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2023,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/0a5d1a8a-eeaf-4fd8-bff8-d0a428aa2fee/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jacob Beaver","dt_posted":"2023-10-20T13:23:26-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1801 K Street NW","registrant_address_2":"Suite 9000","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":400532589,"url":"https://lda.senate.gov/api/v1/registrants/400532589/","house_registrant_id":null,"name":"PRIME POLICY GROUP","description":"Government relations","address_1":"1801 K Street NW","address_2":"Suite 9000","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ABBI SOTHMANN","contact_telephone":"+1 202-530-4574","dt_updated":"2026-01-29T20:20:14.632389-05:00"},"client":{"id":57552,"url":"https://lda.senate.gov/api/v1/clients/57552/","client_id":57552,"name":"QUVA PHARMA, INC.","general_description":"503B outsourcing facility","client_government_entity":null,"client_self_select":false,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-07-21"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Legislation and regulation impacting outsourcing facilities regulated under Section 503B under the Federal Food, Drug, and Cosmetic Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":79181,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":"AUSTEN","last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}